Marvel Biosciences Corp Financial Flexibility Index
Marvel Biosciences Corp financial flexibility index. Marvel Biosciences Corp (MRVL) has a Financial Flexibility Index of -0.04x as of October 2025. Free cash flow of CA$-178.46K (operating CF CA$-178.46K minus capex CA$0.00) represents 0% of total liabilities (CA$4.33 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Marvel Biosciences Corp (2020–2025)
Financial flexibility index of Marvel Biosciences Corp from 2020 to 2025. Historical Financial Flexibility Index trend for Marvel Biosciences Corp across 6 annual periods. Explore MRVL debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Marvel Biosciences Corp Financial Flexibility Index by Year (2020–2025)
Marvel Biosciences Corp financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Marvel Biosciences Corp. For the full cash flow conversion analysis, see Marvel Biosciences Corp (MRVL) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.27x | CA$-1.15 Million | CA$-1.15 Million | CA$4.33 Million | ▲ +25.3% |
| 2024 | -0.36x | CA$-1.18 Million | CA$-1.18 Million | CA$3.32 Million | ▲ +36.1% |
| 2023 | -0.56x | CA$-1.33 Million | CA$-1.33 Million | CA$2.39 Million | ▲ +81.8% |
| 2022 | -3.06x | CA$-2.19 Million | CA$-2.19 Million | CA$718.00K | ▲ +74.9% |
| 2021 | -12.19x | CA$-1.37 Million | CA$-1.37 Million | CA$112.48K | ▼ -300.9% |
| 2020 | -3.04x | CA$-538.53K | CA$-538.53K | CA$177.18K | — |